Randomised double-blind, placebo-controlled trial of coenzyme Q10 therapy in class II and III systolic heart failure

Heart Lung and Circulation

Volumn 12, Issue 3, 2003, Pages 135-141

  Keogh, Anne ^a   Fenton, Steve ^b   Leslie, Christina ^b   Aboyoun, Christina ^a   Macdonald, Peter ^a   Zhao, Yi Chen ^c   Bailey, Michael ^d   Rosenfeldt, Franklin ^c,d  

^a ST VINCENT S HOSPITAL   (Australia)

^b The Sydney Gynaecologic Group   (Australia)

^c ALFRED HOSPITAL   (Australia)

^d MONASH UNIVERSITY   (Australia)

Author keywords

Coenzyme Q10; Heart failure; Systolic heart failure; Ubiquinone

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; NITRATE; PLACEBO; UBIDECARENONE; WARFARIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET SUPPLEMENTATION; DISEASE CLASSIFICATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; EXERCISE TEST; FEMALE; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HOSPITALIZATION; HUMAN; ISCHEMIC HEART DISEASE; LETHARGY; MALE; PHYSICAL ACTIVITY; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SYMPTOM; SYSTOLE; TREATMENT OUTCOME; WALKING;

EID: 0347586774     PISSN: 14439506     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1443-9506.2003.00189.x     Document Type: Article

References (27)

1. 10. Clin. Invest. 1993; 71: S116-23.
2. 10: a new drug for myocardial ischemia? Med. Clin. Nth Am. 1988; 72: 243-58.
3. 10 during heart surgery. Clin. Invest. 1993; 71: S155-61.
4. 10 treatment. Clin. Invest. 1993; 71: S140-44.
5. 10 in human heart disease. Intern. J. Vit. Nutr. Res. 1972; 42: 413-34.
6. Richardson P. In: Bolte H-D (Ed.). Myocardial Biopsy. Diagnostic Significance. Springer, Berlin, 1980; pp. 97-101.
7. 10. Proc. Natl Acad. Sci. USA 1985; 82: 901-4.
8. 10 therapy in patients with congestive heart failure: a long-term multicentre randomised study. Clin. Invest. 1993; 71: S134-6.
9. 10 Drug Surveillance Investigators. Clin. Invest. 1993; 71: S145-9.
10. 10 in dilated cardiomyopathy. Int. J. Tissue React. 1990; 12: 173-8.
11. 10 of patients in heart failure who are eligible or ineligible for transplant. Biochem. Biophys. Res. Commun. 1992; 182: 247-53.
12. 10 therapy for idiopathic dilated cardiomyopathy. Am. J. Cardiol. 1990; 65: 521-3.
13. 10 as adjuvant therapy in heart failure. Clin. Invest. 1993; 71: S129-33.
14. 10 in essential hypertension. Mol. Aspects Med. 1994; 15: S257-63.
15. 10 and conventional therapy. Int. J. Tissue React. 1990; 12: 163-8.
16. Permanetter B, Rossy W, Klein G, Weingartner F, Seid K, Blomer H. Ubiquinone in the long-term treatment of idiopathic dilated cardiomyopathy. Eur. Heart J. 1992; 13: 1528-33.
17. 10 in patients with congestive cardiac failure. J. Am. Coll. Cardiol. 1992; 19: 253A.
18. 10 on left ventricular function in patients with congestive heart failure. J. Am. Coll. Cardiol. 1999; 33: 1549-52.
19. 10 in patients with congestive heart failure. Ann. Intern. Med. 2000; 132: 636-40.
20. 10. Proc. Natl Acad. Sci. USA 1985; 82: 4240-44.
21. 10. Asia Pac. J. Clin. Nutr. 2001; 10: 212-15.
22. 10 illuminated by meta-analysis of clinical trials. Mol. Aspects Med. 1997; 18 (Suppl.): 159-68.
23. 10 protects the aging heart against stress. Ann. NY Acad. Sci. 2002; 959: 355-59.
24. Pavletic AJ. Late angio-oedema in patients taking angiotensin-converting-enzyme inhibitors. Lancet 2002; 360: 493-4.
25. Ko DT, Hebert PR, Coffey CS, Sedrakyan A, Curtis JP, Krumholz HM. Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction. JAMA 2002; 288: 351-7.
26. 10 Association. 2000; 78.
27. Nakamura K, Kusano K, Nakamura Y, Kakishita M, Ohta K, Nagase S et al. Carvedilol decreases elevated oxidative stress in human failing myocardium. Circulation 2002; 105: 2867-71.